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Protein.tyrosine phosphatases (P'l'Pases) are bc¢omintl ~n Important family of" enwmes thai millht rqulal¢ key events in cell Ilrowth and transi'or. 
oration, While i~olatinil, new member of thi~ family via amplification of human lunlit eDNA b~, the pol:imer.se thai. reaction, we found a clone 
identical to but truncated at the 3'.end or tile ¢0dinj relllon of human PTPax~//(HPTP#) mRNA, This dill'eren¢~ in ~qucno= is situated tn tile 
raost conserved part of the catalytic domain of the enzyme. The expression level of the truncated form of ttPTP//mRNA in human lunll was 
lower than its natural form 
Protcin.tyrosine pho=phata~; mRNA; Human lunlil: Polymera~e chain reaction 
I. INTRODUCTION 
The discovery of a family of enzymes catalyzing the 
dephosphorylation f phosphotyrosyl residues is very 
recent. These protein.tyrosine phosphatases (PTPases) 
are probably regulators of protein tyrosine kinase ac- 
tivities (PTKases), the latter ones often being described 
as activators of cell proliferation. In view of the associa- 
tion PTKase-oncogene, PTPases could be defined as 
anti-oncogenes, although their role is probably more 
complex and general than this [1]. PTPase activities 
have been found in numerous mammalian tissues (for a 
review, see [2]), but our knowledge about their role is 
still very limited. 
A cytoplasmic PTPase activity from human placenta 
has been purified and sequenced [3,4]. This 37 kDa pro- 
tein revealed to be homologous to the cytoplasmic part 
of CD45, a leukocyte surface antigen [5]. Since then, 
screening of eDNA libraries with specific degenerate 
oligonucleotides or low-stringency screemng with 
specific DNA probes have revealed a whole family of 
PTPases in several human tissues [6-10] and different 
species, including Drosophila [11-13]. 
All members of the PTPase family share at least one 
very conserved omain which contains the catalytic site 
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deleted in the 3'-end; bp, base pair 
of the enzyme [14]. Until now no [igands are known to 
bird to the extracellular domains of the transmembrane 
PTPases, but the hypothesis for extraceltular factors 
regulating PTPase activity seems plausible in analogy 
• .o . - -  t . I  with receptor-PTKases. The c^.~acedt .a t  par t  Or# "~'*~.J~ 
LAg protein (leukocyte common antigen related 
molecule, a transmembrane PTPasO contains several 
N-CAM (neural-cell adhesion molecule) and fibronee- 
tin type III-like domains which could play a role in cell 
to cell signalling [7]. 
Using degenerate primers based on conserved amino 
acid sequences in the catalytic domain, we isolated via 
PCR and library screening a PTPase sequencing from 
human lung cDNA identical to HPTP/3 but truncated 
near its catalytic site. We report here the natural occur- 
rence of the normal and of this truncated form of 
HPTP/~ mRNA in normal lung tissue. 
2. MATERIALS AND METHODS 
2.1, Oligonueleotides and DNA purification 
Oligonucleotides were synthesized on an Applied Biosystems 391 
PCR-mate DNA synthesizer, Degenerate oligonucleotide primers to 
conserved sequences of the catalytic domain of the PTPase family 
were synthesized (Fig, In), followed by other primers that exactly 
match the determined sequence. One couple of oligonucleotides con- 
tained sequences complementary to MI3 sequencing primers, which 
allowed rapid nucleotide determination of the fragment (Fig. lb), A 
stock of)xgtl I DNA was prepared after amplification of a )~gtl I nor- 
mal human lung eDNA library (Ciontech Laboratories, USA), ac- 
cording to Maniatis et al. [15], DNA was stored at -20°C in H20. 
2.2. RNA purification 
Postsurgical tissues were immediately N2.frozen and stored at 
-80°C. RNA was prepared from human lung and placenta by the 
guanidine thiocyanate/CsCl procedure of Chirgwin et al, [16]. 
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Fig. I. (a) Consensus sequence of the PTPase core domain, The 
single.letter code is used. The 100% conserved amino acid residues are 
in bold type and underlined, Ollgonucleotides synthesised are in- 
dicated above the amino acid sequence, This consensus sequence is 
adapted from Streuli et al. [1 l], the best one available at the time of 
oiigonucIeotide syntl~esis, (b) Sequence of oligonucleotides u ed for 
isolation of 495-bp and 220-bp fragments of HPTPB, UP, universal 
primer; SSP, single stranded primer; Y, C,T 50% each, R, A,G 50olo 
each; i, inosine. (c) 1.2°'/o agarose gel stained with ethidium bromide, 
Lane 1: 123-bp DNA ladder, lane 2: the PCR-amplified 495.bp frag- 
ment from human lung eDNA library with primers IC and 2AZ, lane 
3: as in lane 2 but using primers L3 and 2C (220 bp). 
Messenger RNA (mRNA) was isolated using and mRNA purification 
kit (Pharmacia France). All RNA stocks were stored at -80°C in the 
presence of I mM dithiothreitol and 40 U of RNasin. 
2.3. PCR amplification 
Primers (100 pmol) were used for PCR amplification of DNA 
isolated from a Xgtl I eDNA library, performed in a Perkin-Elmer 
Cetus DNA thermal cycler. The 30-cycle program consisted of 1 min 
94°C denaturation, 1 rain 58°C annealing and 1 rain 72°C extension 
steps. Amplified fragments were separated arm purified by 1,2°70 
agarose gel electrophoresis, excised and electro.eluted. Amplified 
DNA fragments were visualised in the gel by ethidium bromide 
staining, 
2.4. DNA sequencing 
Single-stranded DNA templates for sequencing were obtained by 
asymmetric PCR on purified fragments, Dideoxynucleotide chain- 
termination sequencing of single-stranded templates or fragments 
cloned in M13.mplg/19 vectors was performed using aT7 sequencing 
kit (Pharmaeia) or the Gene-ATAQ kit (Pharmacia) for problematic 
templates [17], Nucleotide sequences were analysed using PC-Gene 
software (lntelligenetics, Switzerland) coupled to the EMBL- 
SwissProt databank. 
2,~, Libud~7 ~¢re~nl.~ na hxbrtdi=.tl.n= 
$~:r¢~ntnl! of the eDNA~ ltbraey (~0000 ,;lanes} Wr~ ~arrl~¢l out u~tn$ 
Lab~lltnlt wns performed I~y the Random Priminll method [ll~] 
(Amersltam, France), Hii!h strinilen~y hybrldl~#tions were performed 
overnlsht =tt 42~C in ~0~. fortnamide ¢onutinln¢ hybridization btlfrer 
[191. Strlnllcnt w~shlnp w~s ~¢rformed InO, lx $$Cti  ~ S$C h IS0 
mM NaCI, I~ mM sodium ¢Itr~te~l, PH %0) m 60"~C for 30 mln, 
Autoradiography wa~, done tar ?2 Is m -~O~C ,sln~ imensiryin$ 
xereens. One positive clone was amplified by asymm~¢tric.PCR and le. 
quenced with Xlttil.spe¢ific primers, For confirmation, the same 
clone was ~1~o inserted into phasic M I;I topiS119 and: sequenced, 
2,6. Revcrxe 'Franseriplion.PCR (RT.PCRJ 
For revers< transcription, ~l ~il or total RNA or I/~g or mRNA were 
Iteated at 95"C in H:O, IO0 pmol of ~peciti~ 3*.anlisense 
oliltonucleolide, 800 ~,M dNTP and reverse transcription buffer was 
added to~etl~er with 200 U of MuMV rev;:~,: tr:~nscrlpiase (BRL, 
Franc~) in a final volume at' 20 M, The reaction was incubated for 15 
rain at room temperature followed by I It at 42"C. The eDNA thus 
produced was directly submitted to PeR amplification by addin~ 100 
pmot or a specific .S'.sense primer. Taq.polymeras¢ buffer and 2,5 U 
of Taq polymerase (Beckman, France) in a final volume of  IO0 ~d. 
GCJ~'rCCCAGAJ~CCAC¢C AGTC~IX~ATCC AGTr'I~TGAGAACTGTCAGGG,~CTAeATC 
0 V P E T T 0 S L Z Q F V R T V R D ¥ Z 
AACAGAAGCC C GGGTGC TGGGC C ¢A CTGSGG~3C AC TGC AGTCK: TGGTGTGGGTA~CT 
N R S P G A a P T V V fl e S A G V O R T 
a 
G2C CAC ATGG ~PTTAC,k, AAAG2~ATC TT~J~,TT AC TAAGC TT'Z'TC e C ATATGTTC TC GT 
v It ~ v L Q R 
AC ~ TC AF, A'/C C e TATAAAGAh'gr A e T?GTTA?C T ATThAJ~AA'I'C TC CTI~&C C CAAA 
'~'C'['GTA'Z".,.'A-~'GT"M'C~"CAAAT A T ATGTGA"~TAGC e CAaAA A~TCC~C AC CT 
TTTG~'C:e TTTTTATGTTTT AA, TTTGAATAATC ATGTGCTTAGTC C C TI'GGTTT&C TGC C A 
CAIN:AG'PI~AACAO GTATACGAChCA'I'TCC C'?TGTCATCA~C AAGG' I 'G~A ~ 
TATTC TTAATTGGATGTTTAAA GC ATGTAC TAC e T~GTTA~TTGGTTTGATGTC~TGGA 
'~TATTC~C ATGAC ATe ATGAGAA~ATGTGTA~TTTTATAe CAC ATTT ATAAAAe ATGATT 
TTC~TTTTCTAC CCTTCAAGGTAAAAACT?A/EAAATAAGGTGGTACTTGTOTAC~TAC 
ATAAAACCAhAATTATAG.. ~:-:-~ - -_- - .  - TTTATATATGAAAATGTCAAAATCAT 
TTTAAAAGTATTATTCG~2~C = Agt, l 1 
ECO RI  
L3 '~. 
GGAGTC ¢ CAGAA~e C ACeCAGTCTCTGATC CAGTTTGTGAGAAeTGTCAGGGACTACATC 
G V P E T T Q S L 1 Q F' v R T V R O Y 1 
1869 
AAe AGA~GCC GGGTGCTGGGC eeACTGTGGTGC&C TGCAGTGCTGGTGTGGGTAGGAeT 
N R S P G A G P T V V H C S A G V G R T 
• 1689 
G~AC C TTTATTGCATTGGAC GAhTCCTCCAGCAGTTAGACTCCAAAGAC TCTGTGGAC 
G T F I A L D B I L Q Q L D ~ ~ D S v D 
1909 
.%TT'?ATGGACK: AGTC, C A e GAC C TAAGAC TTC A,C A q-",.,G TTC AC AT GGTC CAGACTGA GTGT 
Z Y G A V H D L R I~ H R V H M V Q T E C 
1929 
eAGTATGTCTACCTACATeAGTCTGTAAGAGATGTCCTCAGAGCAAGAAAGCTACGGAGT 
O Y V Y L 14 Q e V R D V L R A R ~ L R S 
~4S 
GAACAAGAAAACCCCTTGTTTCCAATC ThTGAAAATGTGAATCCAGAGTATCACAGAGAT 
R (~ E N P L P P 1 Y E N V N P E Y H R D 
- - -  ~-'- _ 1959 
CCAGTCTATTCAAGGCAT~GAATGTAC CTGAAGAGCTCC~TAAAAATTAT?eACT 
P V Y S R H 3'-nor1-cod~(l cont inued  fOE 1,ilk t~ 
1975 
Fig. 2. (a) Nucleotide and deduced amino acid sequence of 
&Y-HPTP~ {clone C22:Y-end). Deduced amino acid sequences are 
shown under the nucleotide sequences using the single-letter code, 
The conserved amino acid residues of the catalytic site are in bold type 
and the indispensable cystein residue marked with an asterisk. The 
first divergent nucleotide with HPTPB. STOP codon and 
polyadenylation signal are in bold type and underlined. Positions of 
primers are above the nucleotide sequence. (b) As in (a) but for 
HPTPB, Amino acid positions of the decuced protein, according to 
Krueger et al. [20], are shown to tlm right below each row, 
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3. RESULTS 
Using a couple of degenerate primers ( IC and 2AZ) 
and purified eDNA of hgt[l human hmg library, a 
PeR-fragment of about 495 bp was produced. By using 
primers L3 and 2C, a second 220,bp fragment was 
found to contain the 3'.extension f  the 495-bp frag- 
ment (Fig. It), Sequence analysis of  these fragments 
revealed an open readin~ frame which contained the 
very conserved amino acids of  the PTPase family 
together with new amino acid residues. The recent 
publication of Krueger e~ al, [201 showed that these 
fragments were identical to the eDNA sequence of the 
catalytic domain of HPTP~ (Fig. 2b), 
By subsequent screening of the Xgtll human lung 
eDNA library with the 49S-bp probe, we isolated a 
1.2-kb clone (C22) that contained a good part of the 3' 
extremity of the HPTP~ mRNA sequence, This eDNA 
clone contained an open reading frame of 627 
nucleotides coding for 209 amino acids. The first 606 
nucleotides and their corresponding 202 amino acids 
(up to resid0e Thr ~m° as in Krueger el el. [20]) were in 
complete agreement with the published educed amino 
acid sequence of HPTPB. Interestingly, the nucleotide 
sequence of this clone showed an in-phase STOP codon 
(TAA) in the most conserved regioa of the PTPase 
family, near the putative catalytic site of the enzyme 
(Fig. 2a). Our deduced protein sequence lacked the 86 
C-terminal residues of HPTP/~ (GlylaOl-Hist97s), The 
STOP codon was followed by a typical A/T-rich 3' 
non.coding sequence of 533 bp, whereafter the Eco RI 
cloning site of the hgtl I vector was found. A putative 
polyadenylation signal sequence was located 40 
nucleotides upstream of this .F.co RI cloning site. The 3' 
non.coding sequence did not belong to any known 
mRNA (EMBL 21 databank, release 3.0, February 
1990), neither to the PTPase family of mRNAs describ- 
ed until now. 
Verification of the expression of the truncated type 
HPTPgt mRNA, for which we propose the name 
A3'-HPTP3, was performed by RT-PCR. This techni- 
que nowadays seems more powerful than classical Nor- 
thern blot analysis to detect the presence of rare 
mRNAs, provided that PCg-amplified fragments are 
subsequently verified by nucleotide sequencing. We us- 
ed antisense primers C22-STOP and ~-STOP (see Fig. 
2), respectively to the A3'-HPTP~ and HPTP3 mRNA 
sequences, for reverse transcription followed by PeR 
with the L3 sense primer (Fig. 3a). Total RNA from 
human placenta nd from human lung tissue was sub- 
mitted to RT-PCR with the ~-STOP oligonucleotide 
specific for the HPTP~ C-terminal e×tremity and with 
a specific sense primer (L3). Fig. 3b shows the 
theoretically expected 368-bp fragment for HPTP3 
mRNA in both tissues, demonstrating for the first time 
the expression of this mRNA in human lung. We have 
always found a lower expression level in the latter 
C]|.O~I['OP 
L ]  
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Fill. 3. (a) Sequences of oligonucleotldes used for the isolation of 
245-bp (A3'.HPTP~t specific) and ~68-bp (HPTB~ specific) 
fragments. The ttind lit site in B.STOP is for subsequent cloning 
facilitation. (b) 1.2% agarose gel stained with ethidium bromide. 
Lane h 123.bp DNA ladder, lane 2: RT-PCR on 3 ~g human lung 
RNA with/~.STOP and L3 primers, lane 3: RT.PCR on 3/qt human 
lung RNA with ,~-STOP and L3 primers, lane 4: RT-PCR on Iug 
human lung mRNA with C22-STOP and L3 primers, lane ~: PeR on 
clone C22 DNA with C22-STOP and L3 primers. 
tissue. We only detected a very faint band of the ex- 
pected size for A3'-HPTPfl mRNA (245 bp) in total 
RNA from human lung (not shown). By enrichment to 
purified mRNA from human lung tissue we were able to 
detect clearly the truncated A3'-FIPTP/3 mRNA (Fig. 
3b). This result reflects the low level expression of 
A3' -HPTP/3 mRNA in human lung. Nucleotide sequen- 
cing confirmed the presence of the (TAA)-STOP codon 
in this fragment. We also verified the presence of this 
sequence in the eDNA library by PCR amplification 
and nucleotide sequencing (Fig. 3b). 
4. DISCUSSION 
Although discovered much more recently, the 
PTPases are emerging as large a family as the PTKases, 
It is becoming clear that in the field of signal transduc- 
tion PTPases will have to be considered as important as 
PTKases, with both types of enzymes taking part in the 
complex regulation of a proliferative signal. One exam- 
ple of such a regulatory mechanism is provided by a 
couple PTPase-PTKase in T-cells: the CD45 antigen 
activates the PTKase pp56 t:k by dephosphorylation f 
its tyrosine-505 residue, activation of pp56 tck by CD45 
appearing to play a crucial role in T-cell activation [21 ]. 
Until very recently it was believed that the PTPase 
family could be subdivided into two classes: transmem- 
brane PTPases containing two repetitive homologous 
domains and cytoplasmic PTPases containing one such 
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domain. Tl~e recent finding of the HPTP~ sequence, a 
transmembrane PTPa~¢ with only one homolottou~ do- 
n~ain, makes this subdivision somewhat artificial [20], 
The PTPase activity of HPTPgi seems to be very hi~!h 
relative to other PTPases, as measured in vitro usin~l 
phosphotyrosyl protein substrates [201. The 
physiological substrates o1' this enzyme have not been 
found, yet, Because HPTPB contains only one catalytic 
domain, mutations or deletions near tla¢ conserved 
catalytic site in this particular P°rPase will probably 
dramatically change its enzymatic activity. This has 
already been shown for the LAg protein where PTPase 
activity was abolished by site-directed mutagenesis of 
the cystein residue in this region [141. 
The use of degenerate oligonucleotide primers for 
PCR to conserved parts of the catalytic domain of the 
PTPase family revealed to be successful for isolating a
new member of this family in human lung. Recently, by 
using the same approach, 11 different partial eDNA 
clones belonging to the PTPase family were isolated 
from human liver, including HPTP,~ [221. 
The isolation of a variant HPTPB clone in a human 
lung eDNA library, truncated near the catalytic site of 
the enzyme, seems very important to us. We 
demonstrated the natural existence of this variant 
mRNA (zX3'-HPTP/~) in a fresh RNA preparation of 
lung tissue by RT-PCR. The normal HPTPB mRNA is 
expressed at  higher level than the A3'-HPTP/'J mRNA 
in lung tissue. Indeed, we noted a more intense band 
(ethidium bromide staining) for the 368-bp fragment 
(HPTP/~) than for the 245-bp band (:,3'-HPTP/~ -
hardly visible), both being amplified from the same 
amount of total RNA. In fact we needed 1 #g of mRNA 
to clearly visualize the A3'-HPTPB specific fragment. 
As to the origin of A3'.HPTP/3 mRNA, this might 
occur by alternative splicing m a way similar to 
leukocyte antigen related protein (LRP), where an alter- 
nate insertion was found to disrupt he first PTPase do- 
main [12]. However it will be necessary to characterise 
this fragment on the genomic DNA level to know 
whether only one gone is expressed. 
The physiological meaning of the difference in 
mRNA expression level between the two forms is still 
unclear, but if a difference in enzymatic activity be- 
tween them also exists, the regulation f certain specific 
substrates intervening in cell growth might be disturb- 
ed. From these types of experiments it is hard to tell if 
both mRNAs are present at the same time in one cell, 
but 'in situ' hybridizations may answer this question. 
One can hypothesize two ways about this truncated 
PTPase: either it has lost part or all of its enzymatic ac- 
tivity due to disruption of the catalytic site environ- 
ment~ or it has become constitutively active. It could be 
possible that part of the regulation of HPTP/~ activity 
resides in the C-terminal extremity through protein 
phosphorylation. We noted that a putative casein 
kinase II phosphorylation site is present on serine 
rcsid,tae 1949 of HPTP~J [231. We are actually analy~in~t 
the PTPase ae.,tvity of the ,,~3'=HPTP~ catalytic do- 
main in compari~on with its HPTPgl analog, 
Anothce lmp~ ~ ~ant research axis, whlcl~ i~ part or our 
future Sttldh:s, r~ ~o analyse the ¢~pression levels or the 
~3" -HPTPI~ mRNA and protein in tumoral tissue eom. 
pared to normal tissue. 
Arknlt~wl~lltnrw/ltlt: The ~tuth~r~ wid~ Io Ib~l~k Prof, (~, Dd~ol rot 
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